BioCentury
ARTICLE | Company News

GlaxoSmithKline sales and marketing update

September 2, 2013 7:00 AM UTC

GlaxoSmithKline will discontinue the manufacture and sale of cancer drug Bexxar tositumomab, effective Feb. 20, 2014. The company said it decided to discontinue the product because "use of Bexxar has...